Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China · Delayed Price · Currency is CNY 16.11
-0.35 (-2.13%)
Aug 31, 2026, 3:00 PM CST
SHA:600521 Revenue
Zhejiang Huahai Pharmaceutical had revenue of 2.58B CNY in the quarter ending June 30, 2026, with 20.00% growth. This brings the company's revenue in the last twelve months to 8.98B, up 0.54% year-over-year. In the year 2025, Zhejiang Huahai Pharmaceutical had annual revenue of 8.59B, down -10.06%.
Revenue (ttm)
8.98B
Revenue Growth
+0.54%
P/S Ratio
2.67
Revenue / Employee
1.02M
Employees
8,797
Market Cap
24.01B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.59B | -960.28M | -10.06% |
| Dec 31, 2024 | 9.55B | 1.24B | 14.91% |
| Dec 31, 2023 | 8.31B | 42.97M | 0.52% |
| Dec 31, 2022 | 8.27B | 1.62B | 24.42% |
| Dec 31, 2021 | 6.64B | 158.36M | 2.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsZhejiang Huahai Pharmaceutical News
- 5 days ago - Zhejiang Huahai Pharmaceutical Quarterly report: Q2 2026 - Filings
- 4 months ago - Zhejiang Huahai Pharmaceutical Annual report: Q4 2025 - Filings
- 4 months ago - Zhejiang Huahai Pharmaceutical Quarterly report: Q1 2026 - Filings
- 10 months ago - Zhejiang Huahai Pharmaceutical Quarterly report: Q3 2025 - Filings